Jason Shafrin

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Sickle Cell Disease

Duchenne Muscular Dystrophy

Obstructive Sleep Apnea

Top Venues

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis

Journal of medical Internet research

Annals of the American Thoracic Society

ClinicoEconomics and outcomes research : CEOR

This page only lists publications with an associated author ORCID identifier.

Publications

Denise Clayton, Jason Shafrin, Glorian Yen, Soyon Lee, Lincy Geevarghese, Yulin Shi, Luyang He, Ying Shen, Anem Waheed
Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Ryan Fischer, Patricia Furlong, Annie Kennedy, Kelly Maynard, Marissa Penrod, Debra Miller, Chamindra G Laverty, Linda P Lowes, Nancy L Kuntz, Perry B Shieh, Jane Kondejewski, Peter J Neumann, Jason Shafrin, Richard J Willke
Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies. Journal of multidisciplinary healthcare 17 (2024)
Denise Clayton, Jason Shafrin, Glorian Yen, Soyon Lee, Lincy Geevarghese, Yulin Shi, Luyang He, Ying Shen, Anem Waheed
Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
David E Ost, Fabien Maldonado, Jason Shafrin, Jaehong Kim, Moises A Marin, Tony B Amos, Deanna S Hertz, Iftekhar Kalsekar, Anil Vachani
Economic Value of Bronchoscopy Technologies that Improves Sensitivity for Malignancy for Peripheral Pulmonary Lesions. Annals of the American Thoracic Society (2024)
Denise Clayton, Jason Shafrin, Glorian Yen, Soyon Lee, Lincy Geevarghese, Yulin Shi, Luyang He, Ying Shen, Anem Waheed
Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 30 (2024)
Jason Shafrin, Kyi-Sin Than, Anmol Kanotra, Kirk W Kerr, Katie N Robinson, Michael C Willey
Use of Conditionally Essential Amino Acids and the Economic Burden of Postoperative Complications After Fracture Fixation: Results from a Cost Utility Analysis. ClinicoEconomics and outcomes research : CEOR 15 (2023)
Christian Jackisch, Federico Manevy, Suzanne Frank, Nicki Roberts, Jason Shafrin
White Paper on the Value of Time Savings for Patients and Healthcare Providers of Breast Cancer Therapy: The Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection as an Example. Advances in therapy 39 (2) (2022)
Suepattra G May, Caroline Huber, Meaghan Roach, Jason Shafrin, Wade Aubry, Darius N Lakdawalla, John M Kane, Felicia Forma
Adoption of Digital Health Technologies in the Practice of Behavioral Health: Qualitative Case Study of Glucose Monitoring Technology. Journal of medical Internet research 23 (2) (2021)
Jason Shafrin, Howard H Z Thom, Edna Keeney, Daisy M Gaunt, Lauren M Zhao, Menaka Bhor, Avery A Rizio, Lanetta Bronté-Hall, Nirmish Shah
The impact of vaso-occlusive crises and disease severity on quality of life and productivity among patients with sickle cell disease in the US. Current medical research and opinion 37 (5) (2021)